SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001437749-23-007116
Filing Date
2023-03-20
Accepted
2023-03-17 18:03:21
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM POS AM pbla20230317_posam.htm POS AM 814181
2 EXHIBIT 23.1 ex_490181.htm EX-23.1 2712
3 image01.jpg GRAPHIC 3298
4 image02.jpg GRAPHIC 45764
5 image03.jpg GRAPHIC 32091
6 image04.jpg GRAPHIC 23607
  Complete submission text file 0001437749-23-007116.txt   962846
Mailing Address 712 VISTA BLVD #305 WACONIA MN 55387
Business Address 712 VISTA BLVD #305 WACONIA MN 55387 9524791196
Panbela Therapeutics, Inc. (Filer) CIK: 0001029125 (see all company filings)

IRS No.: 870543922 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-269711 | Film No.: 23744188
SIC: 2834 Pharmaceutical Preparations